Home > Press > Bio Nano Consulting (BNC) announces latest contract
BNC and Oxford Immunotec work together to improve infectious disease diagnosis and monitoring
Bio Nano Consulting (BNC) announces latest contract
London, UK | Posted on July 31st, 2008
Bio Nano Consulting (BNC), the specialist bionanotechnology product development consultancy, today announced that it has commenced a project with international T cell measurement company, Oxford Immunotec. BNC is applying its expertise in nano-characterisation to assist Oxford Immunotec in a project related to its novel Enzyme-Linked ImmunoSPOT (ELISPOT) system. As specialists in bio-nanotechnology, BNC is able to utilise the world-leading nano-characterisation facilities at the Institute of Biomedical Engineering, Imperial College London.
Oxford Immunotec is commercialising a diagnostic test to detect tuberculosis (TB) based on its patented T-SPOT technology, effectively providing a new way to diagnose and monitor this deadly disease. The World Health Organization (WHO) has estimated that almost 1.6 million deaths resulted worldwide from TB in 2005.
The developing field of bionanotechnology promises great advances in medicine, particularly in the areas of diagnostics and therapeutics. By collaborating with Oxford Immunotec, BNC is facilitating the development of precise, accurate techniques to diagnose and monitor infection and disease.
About Bio Nano Consulting (BNC)
The BNC is a specialist research and development consultancy operating in the convergent field of bionanotechnology. A joint venture of Imperial College London and University College London, the BNC is funded through the Technology Strategy Board (TSB) with additional support from the London Development Agency (LDA).
Along with its partner organisation, the National Physical Laboratory (NPL), the BNC offers a service to the biomedical and healthcare industries in microsystems and nanotechnology. This encompasses design, 3-D modelling and visualisation, rapid prototyping, and characterisation.
About Oxford Immunotec
Oxford Immunotec, the T cell measurement company is based in Oxford, UK and Marlborough, MA. The Company develops and sells clinical diagnostic products based on its patented T-SPOT® technology, the first regulatory approved method for directly quantifying antigen-specific T cells. T-SPOT is a simple and extremely accurate method of studying a person’s cellular immune response to infection and can be applied to diagnose and monitor any major disease driven by a T cell response.
T-SPOT® is a trademark of Oxford Immunotec.
For more information please see: www.oxfordimmunotec.com
For more information, please click here
Bio Nano Consulting
Dr David Sarphie – CEO
t: +44 (0)207 268 3032
Alto Marketing Limited
t: +44 (0)1489 557672
Copyright © Bio Nano Consulting
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
News and information
JPK announces expansion of its global sales and service activities in China and USA April 15th, 2014
Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014
PAM-XIAMEN Offers UV LED wafer April 15th, 2014
Engineers develop new materials for hydrogen storage April 15th, 2014
Harris & Harris Group Announces the Consulting Engagement of Peter J. Boni as a Senior Advisor February 26th, 2014
NEI Corporation Introduces Prototyping Service for Electrospinning of Fibers January 23rd, 2014
Production of Geopolymers Strengthened by Silicon, Alumina Nanoparticles February 12th, 2013
‘Optical Microscopy over the Web’. NanoScope Services has extended it’s unique LiveFIBTM focused ion beam web conferencing capability, with high resolution Optical Microscopy January 31st, 2013
Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014
A molecular approach to solar power: Switchable material could harness the power of the sun — even when it’s not shining April 15th, 2014
Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014
Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014
Industrial Nanotech, Inc. Lands First Major Order from Pemex, Mexico’s State-Owned Oil and Gas Company April 14th, 2014
TED Selects Nanotech for Branding and Security on 30th Anniversary Conferences: Nanotech and TED collaborate to create a custom security feature using nano-imaging March 17th, 2014
Simon Fraser University Completes Installation of Electron Microscopes from FEI: SFU’s new multi-million-dollar Centre for Soft Materials now offers the most advanced suite of microscopes in Western Canada March 11th, 2014
Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 March 3rd, 2014